We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.16B
AUM Growth
+$235M
Cap. Flow
+$21.9M
Cap. Flow %
1.01%
Top 10 Hldgs %
37.62%
Holding
102
New
26
Increased
22
Reduced
15
Closed
27

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$157M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$34.1M
3
NVRO
NEVRO CORP.
NVRO
+$28.6M
4
GILD icon
Gilead Sciences
GILD
+$28.1M
5
PEN icon
Penumbra
PEN
+$26.9M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$92.8M
2
MCK icon
McKesson
MCK
+$50.5M
3
CAH icon
Cardinal Health
CAH
+$45.2M
4
LH icon
Labcorp
LH
+$30.8M
5
BAX icon
Baxter International
BAX
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 67.91%
2 Technology 4.93%
3 Consumer Discretionary 1.42%
4 Industrials 0.78%
5 Utilities 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OM icon
1
Outset Medical
OM
$78M
$131M 6.04%
+191,533
New +$157M
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$114M 5.28%
1,343,570
-1,835,404
-58% -$92.8M
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$460B
$106M 4.9%
381,500
+102,100
+37% +$27.7M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$106M 4.88%
1,359,420
+216,942
+19% +$14.9M
ALXN
5
DELISTED
Alexion Pharmaceuticals
ALXN
$80.5M 3.72%
703,817
+24,933
+4% +$2.69M
GILD icon
6
Gilead Sciences
GILD
$163B
$68.1M 3.15%
1,078,089
+404,677
+60% +$28.1M
ICUI icon
7
ICU Medical
ICUI
$3.84B
$55.4M 2.56%
302,999
+77,448
+34% +$14.6M
IQV icon
8
IQVIA
IQV
$34.5B
$53.3M 2.46%
337,987
+50,449
+18% +$7.91M
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$11.4B
$53.3M 2.46%
700,052
+216,973
+45% +$22M
PEN icon
10
Penumbra
PEN
$12.5B
$46.5M 2.15%
239,397
+128,095
+115% +$26.9M
HCA icon
11
HCA Healthcare
HCA
$83.6B
$45.5M 2.1%
364,940
+35,583
+11% +$4.4M
NVRO
12
DELISTED
NEVRO CORP.
NVRO
$44.3M 2.05%
318,232
+214,052
+205% +$28.6M
ABBV icon
13
AbbVie
ABBV
$453B
$43.9M 2.03%
501,750
-142,838
-22% -$13.4M
RCUS icon
14
Arcus Biosciences
RCUS
$3.73B
$43.5M 2.01%
2,536,932
+801,351
+46% +$17.9M
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$41.4M 1.91%
+249,068
New +$34.1M
IRTC icon
16
iRhythm Holdings
IRTC
$3.54B
$39.8M 1.84%
167,008
-81,550
-33% -$14.4M
EW icon
17
Edwards Lifesciences
EW
$48.1B
$38.9M 1.8%
487,842
+94,407
+24% +$7.37M
DHR icon
18
Danaher
DHR
$135B
$35.2M 1.63%
184,612
-9,766
-5% -$1.74M
PFE icon
19
CALL
Pfizer
PFE
$143B
$34M 1.57%
+976,004
New +$34.2M
HUM icon
20
Humana
HUM
$47.2B
$32.2M 1.49%
77,740
-8,280
-10% -$3.33M
MOH icon
21
Molina Healthcare
MOH
$10.5B
$29.7M 1.38%
162,524
+69,356
+74% +$12.6M
XYZ
22
Block Inc
XYZ
$45.8B
$29.5M 1.36%
181,509
– –
PPD
23
DELISTED
PPD, Inc. Common Stock
PPD
$29.1M 1.35%
787,863
-285,628
-27% -$9.05M
AVTR icon
24
Avantor
AVTR
$7.74B
$28.6M 1.32%
+1,270,070
New +$26.4M
MRK icon
25
CALL
Merck
MRK
$323B
$28.2M 1.3%
+356,320
New +$27.9M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q3 2020 Portfolio in Review

As of Q3 2020, PFM Health Sciences held 102 positions worth $2.16B, up 12% from $1.93B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PFM Health Sciences's Q3 2020 filing shows 26 new, 22 increased, 15 reduced and 27 closed positions. Its largest new stake was Outset Medical: 191,533 shares worth $131M. The largest sale was Immunomedics Inc, an estimated $92.8M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 67% a quarter earlier, followed by Technology and Consumer Discretionary.

  • PFM Health Sciences's largest Q3 2020 buy was Outset Medical: 191,533 shares worth $131M.
  • PFM Health Sciences added most to NEVRO CORP. in Q3 2020, an estimated $28.6M increase.
  • PFM Health Sciences's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $92.8M.
  • PFM Health Sciences fully exited McKesson in Q3 2020, selling an estimated $50.5M.
  • PFM Health Sciences's ten largest holdings make up 38% of its $2.16B portfolio in Q3 2020.
  • PFM Health Sciences opened 26 new positions and closed 27 in Q3 2020.
  • PFM Health Sciences's portfolio value rose 12% quarter-over-quarter to $2.16B.

Based on PFM Health Sciences's 13F filing for Q3 2020, filed 16 Nov 2020.